Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P030045/S011

Visi-Pro balloon-Expandable peripheral stent system

Medtronic Vascular, Inc. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONP030045/S011

What did the FDA decide?

The FDA recorded a 30-Day Notice decision, OK30, dated 2026-10-16 for P030045/S011, a supplement to the Visi-Pro balloon-Expandable peripheral stent system held by Medtronic Vascular, Inc. The supplement type is listed as a 30-Day Notice with the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the device is categorized as an iliac stent under product code NIO in the Cardiovascular specialty.

The recorded statement covers a sterilization monitoring change: reduced incubation time for the biological indicator used in external process challenge devices. This is a manufacturing process notice, not a new approval of the stent system itself, and the source does not describe the prior or revised incubation interval, the indicator or device maker, or any validation data. No documents are attached, so the sterilization rationale and any effect on finished-device labeling remain unknown from this record.

FDA approval order statement

approval for a sterilization monitoring change to reduce incubation time for the biological indicator used in external process challenge devices
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P030045/S011
Regulatory pathway
PMA supplement
Product code
NIO
Decision code
OK30
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, ILIAC.

Product code
NIO
FDA device class
3

For the original device and its historical approval scope, see PMA P030045. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P030045 · Original PMA

    INTRASTENT DOUBLESTRUT STENT

  2. P030045/S011 received

    Application receipt date recorded by FDA.

  3. P030045/S011 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P030045. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P030045

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Vascular, Inc.PMA approvalJun 8, 2004FDA

Explore the linked device profile

Other records with product code NIO

Product / regulatory recordCompanyPathwayDecision dateSource
Cook Ireland, Ltd.PMA supplementNov 6, 2026FDA
Cordis US CorporationPMA supplementOct 15, 2026FDA
Biotronik AGPMA supplementSep 11, 2026FDA
Biotronik AGPMA approvalDec 17, 2015FDA
Cook Ireland, Ltd.PMA approvalJun 26, 2006FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Vascular, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3033 Campus Dr., Plymouth, MN, 55441

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records